To be clear: there's no human data showing BPC-157 actually accelerates tumor growth, and a 2020 study (PubMed 31158953) showed BPC-157 inhibits TNF-, which is the opposite of what a pro-cancer compound would do
The reconstitution and syringe-draw formula structure is the same across both, but their typical vial strengths and dosing conventions differ always use the actual labeled strength of your specific vial rather than assuming the two are interchangeable
In a general weightloss setting, tesamorelin is sometimes discussed offlabel for visceral fat reduction, but any such use sits outside its primary FDA indication and should only be considered within a comprehensive medical plan, not as a cosmetic shortcut. Ready to Start a Plan That Works
Most of the studies done so far have been in rodents -- results that dont always hold up when larger studies are done in people
Enjoy the convenience of receiving safe, effective injections without the hassle of clinic visits or waiting times, fitting seamlessly into your busy schedule